Clinical Trial Update: Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating levetiracetam for children with Subclinical Sleep-Activated Epileptiform Activity and CSWS. The current status of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Continuous Spikes and Waves During Slow Sleep
• Electrical Status Epilepticus During Sleep
• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Oslo University Hospital | Conditions: Subclinical Sleep-Activated Epileptiform Activity, CSWS | Phase 4 | Status: UNKNOWN